Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

355
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
355
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF01:24

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

173
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
173
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

152
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
152
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

215
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
215

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Impact of Paediatric-Onset Inflammatory Bowel Disease on Educational Paths and Careers.

Inflammatory intestinal diseases·2026
Same author

Clinical and radiological outcomes of ustekinumab in pediatric perianal Crohn's disease: a multicenter retrospective study from the Pediatric IBD Porto Group of ESPGHAN.

Inflammatory bowel diseases·2026
Same author

Genomic association of Campylobacter concisus for colonization advantages and virulence in children and adolescents with inflammatory bowel disease.

BMC microbiology·2026
Same author

Reduction in mucosal phosphorylated STAT3 under therapy with JAK inhibitor in STAT3 gain of function mutation - a case study.

Virchows Archiv : an international journal of pathology·2026
Same author

Evolution of Growth following Anti-Tumor Necrosis Factor-α Therapy in Paediatric Crohn's Disease: Data from the Swiss IBD Cohort Study.

Inflammatory intestinal diseases·2025
Same author

Patterns of complementary and alternative medicine use in pediatric patients with inflammatory bowel disease.

Journal of pediatric gastroenterology and nutrition·2025

Related Experiment Video

Updated: Jul 19, 2025

Author Spotlight: Developing Immunocompetent Organ-on-Chip Models for Infectious Disease Research
08:48

Author Spotlight: Developing Immunocompetent Organ-on-Chip Models for Infectious Disease Research

Published on: May 24, 2024

1.7K

Machine Learning in Antibody Diagnostics for Inflammatory Bowel Disease Subtype Classification.

Christiane Sokollik1, Aurélie Pahud de Mortanges2, Alexander B Leichtle3,4

  • 1Division of Pediatric Gastroenterology, Hepatology and Nutrition, University Children's Hospital, Inselspital, University of Bern, 3010 Bern, Switzerland.

Diagnostics (Basel, Switzerland)
|August 12, 2023
PubMed
Summary

Antibody testing aids in diagnosing Crohn's disease (CD) and ulcerative colitis (UC) but struggles to differentiate IBD-unclassified (IBD-U) cases. Machine learning models did not improve subtype distinction for IBD-U.

Keywords:
ASCACrohn’s diseasePR3-ANCAserologyulcerative colitis

More Related Videos

Fluorescence-mediated Tomography for the Detection and Quantification of Macrophage-related Murine Intestinal Inflammation
07:05

Fluorescence-mediated Tomography for the Detection and Quantification of Macrophage-related Murine Intestinal Inflammation

Published on: December 15, 2017

8.3K
Colorectal Cancer Cell Surface Protein Profiling Using an Antibody Microarray and Fluorescence Multiplexing
15:17

Colorectal Cancer Cell Surface Protein Profiling Using an Antibody Microarray and Fluorescence Multiplexing

Published on: September 25, 2011

14.0K

Related Experiment Videos

Last Updated: Jul 19, 2025

Author Spotlight: Developing Immunocompetent Organ-on-Chip Models for Infectious Disease Research
08:48

Author Spotlight: Developing Immunocompetent Organ-on-Chip Models for Infectious Disease Research

Published on: May 24, 2024

1.7K
Fluorescence-mediated Tomography for the Detection and Quantification of Macrophage-related Murine Intestinal Inflammation
07:05

Fluorescence-mediated Tomography for the Detection and Quantification of Macrophage-related Murine Intestinal Inflammation

Published on: December 15, 2017

8.3K
Colorectal Cancer Cell Surface Protein Profiling Using an Antibody Microarray and Fluorescence Multiplexing
15:17

Colorectal Cancer Cell Surface Protein Profiling Using an Antibody Microarray and Fluorescence Multiplexing

Published on: September 25, 2011

14.0K

Area of Science:

  • Gastroenterology
  • Immunology
  • Computational Biology

Background:

  • Antibody testing improves inflammatory bowel disease (IBD) subtype diagnosis.
  • The utility of machine learning for classifying IBD-unclassified (IBD-U) is unknown.

Purpose of the Study:

  • To evaluate antibody profiles and machine learning for IBD subtype classification.
  • To assess the diagnostic value for Crohn's disease (CD), ulcerative colitis (UC), and IBD-U.

Main Methods:

  • Analyzed antibody profiles (ASCA, p-ANCA, MPO-ANCA, PR3-ANCA, xANCA) in 100 CD/UC and 76 IBD-U patients.
  • Applied supervised and unsupervised machine learning models.
  • Calculated AUC for antibody panels distinguishing CD from UC.

Main Results:

  • An optimized antibody panel achieved 85% AUC for CD vs. UC distinction.
  • IBD-U patients showed antibody profiles similar to UC.
  • Machine learning models failed to differentiate CD, UC, and IBD-U.
  • Unsupervised learning suggested only two IBD subtypes.

Conclusions:

  • Antibodies support CD and UC diagnosis but have limited predictive value for IBD-U.
  • IBD-U is not a distinct subtype based on antibody profiles.
  • Antibody panels showed moderate accuracy (69.2-73.1%) for UC reclassification prediction.